Review article

Myasthenia Gravis

Pathogenesis and Immunotherapy

Dtsch Arztebl 2007; 104(7): A-420

Schneider-Gold, C; Toyka, K V

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Hohlfeld R, Melms A, Schneider C, Toyka KV, Drachman DB: Therapy of myasthenia gravis and myasthenic syndromes. In: Brandt T, Caplan LR, Dichgans J, Diener HC, Kennard C (eds.): Neurological disorders – course and treatment. Amsterdam: Elsevier 2003: 1341–62.
2. Osserman KE, Genkins G: Studies in myasthenia gravis: review of a twenty-year experience in over 1 200 patients. Mt Sinai J Med 1971; 38: 497–537. MEDLINE
3. Melms A, Gold R, Hohlfeld R, Schalke B, Schumm F, Toyka KV: Myasthenie. In: Diener HC, Putzki N, Berlit P (Hrsg.): Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart; Thieme Verlag 2005; 568–82.
4. Toyka KV: Ptosis in myasthenia gravis: extended fatigue and recovery bedside test. Neurology 2006; 67: 1524. MEDLINE
5. Besinger UA, Toyka KV, Homberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A: Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 1983; 33: 1316–21. MEDLINE
6. Lindstrom J: An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol 1977; 7: 36–43. MEDLINE
7. Toyka KV, Drachman DB, PestronkA, Kao I: Myasthenia gravis. Passive transfer from man to mouse. Science 1975; 190: 397–99.
8. Heininger K, Hartung HP, Toyka KV, Gaczkowski A, Borberg H: Therapeutic plasma exchange in myasthenia gravis: semiselective adsorption of Anti-AChR autoantibodies with tryptophane-linked polyvinylalcohol gels. Ann N Y Acad Sci 1987; 505: 898–900.
9. Bufler J, Pitz R, Czep M, Wick M, Franke C: Purified IgG from seropositive and seronegative patients with myasthenia gravis reversibly block currents through nicotinic acetylcholine receptor channels. Ann Neurol 1998; 43: 458–64. MEDLINE
10. Hohlfeld R, Wekerle H: The immunopathogenesis of myasthenia gravis. In: Engel AG (Hrsg.): Myasthenia gravis and myasthenic syndromes. Oxford University Press, Oxford, 1999: 87–110.
11. Vincent A, Bowen J, Newsom-Davis J, McConville J: Seronegative generalised myasthenia gravis: clinical features, antibodies and their targets. Lancet Neurology 2003; 2: 99–1065. MEDLINE
12. Leite MI, Strobel P, Jones M et al.: Fewer thymic changes in MuSK-positive than in MuSK-negative MG. Ann Neurol 2005; 57: 444–48. MEDLINE
13. Ströbel P, Marx A, Zettl A, Müller-Hermelink HK: Thymoma and thymic carcinoma: an update of the WHO Classification 2004. Surg Today 2005; 35: 805–11. MEDLINE
14. Ströbel P, Rosenwald A, Beyersdorf N et al.: Selective loss of regulatory T-cells in thymomas. Ann Neurol 2004; 56: 901–4. MEDLINE
15. Schneider C, Reiners K: Elektrophysiologische Diagnostik neuromuskulärer Übertragungsstörungen. Klin Neurophysiol 2000; 31: 122–35.
16. Marienhagen J, Schalke B, Aebert H, Held P, Eilles C, Bogdahn U: Somatostatin receptor scintigraphy in thymoma imgaing method and clinical application. Pathol Res Pract 1999; 195: 575–81. MEDLINE
17. Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR:Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev 2005; CD002828. MEDLINE
18. Tindall RSA, Phillips JT, Rollins JA, Wells L, Hall K: A clinical therapeutic trial of ciclosporine in myasthenia gravis. Ann N Y Acad Sci 1993; 681: 539–51. MEDLINE
19. Palace J, Newsom-Davis J, Lecky B: A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Neurology 1998;50: 1778–83. MEDLINE
20. Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C: Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurology 1997; 41: 789–96. MEDLINE
21. Gronseth GS, Barohn RJ: Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Neurology 2000; 55: 7–15. MEDLINE
22. Michels M, Hohlfeld R, Hartung HP, Heininger K, Besinger UA, Toyka KV: Myasthenia gravis: discontinuation of longterm azathioprine. Ann Neurol 1988; 24: 798. MEDLINE
23. Schneider-Gold C, Hartung HP, Gold R: Mycophenolate mofetil and tacrolimus: new therapeutic options in the therapy of neuroimmunological diseases. Muscle Nerve 2006; 34: 284–91. MEDLINE
24. Drachman DB, Jones RJ, Brodsky RA: Treatment of refractory myasthenia gravis: Rebooting with high dose cyclophosphamide. Ann Neurol 2003; 53: 29–34. MEDLINE
25. Thomas CE, Mayer SA, Gungor Y: Myasthenic crisis: clinical features, mortality, complications and risk factors for prolonged intubation. Neurology 1997; 48: 1253–60. MEDLINE